Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Kathy Giusti to Address HBS Graduating Class
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
Admissions after Affirmative Action
The composition of colleges’ incoming class after the Supreme Court ruling
“Find Yourself a Teacher…”
President Garber’s Morning Prayers
Convocation 2024: The New Crew Redux
Welcoming the class of 2028 to a challenged Harvard
Most popular
More to explore
Brain Mapping Suggests How Memories are Stored
A decade-long project to map a cubic millimeter of human brain reveals previously unimagined architectures.
Harvard Author Behind Afrofuturist Trilogy “Blood and Bone”
The reality-based fantasies of novelist Tomi Adeyemi